Irinotecan in combination with CDDP or 5-FU and folinic acid is active in patients with advanced gastric of gastro-oesophageal junction adenocarcinoma: final results of a randomized phase II study. - Pozzo,C.; Bugat,R.Peschel C. (Proc Am Soc Clin Oncol, 2001)